Blockade of the neurotensin 1 receptor by antagonists (e.g., SR48692) promotes apoptosis in glioma cells and sensitizes these cells to antinomycin D or doxorubicin [56]. This evidence concerns the gene NTSR1 and central nervous system cancer.